Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Oxfendazole by Oxfendazole Development Group for Neurocysticercosis: Likelihood of Approval
Oxfendazole is under clinical development by Oxfendazole Development Group and currently in Phase I for Neurocysticercosis. According to GlobalData, Phase...